Lipid Nanoparticles (LNP) Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outl

Forecast 2025-2032 Published On : 04 july 2025

• The global lipid nanoparticles (LNP) market size was valued at USD 460 million in 2024. The market is projected to grow from USD 500 million in 2025 to USD 774 million by 2032, exhibiting a CAGR of 7.9% during the forecast period.

Email:  help@intelmarketresearch.com +91 9169164321

Report Studies

• Lipid nanoparticles are liposome-like structures specifically designed to encapsulate various nucleic acids (RNA and DNA), making them the most widely used non-viral gene delivery system. These nanoparticles efficiently transport genetic payloads such as siRNA, mRNA, and saRNA, enabling targeted therapeutic applications. Their unique composition allows for enhanced stability and controlled release of bioactive molecules.

Email:  help@intelmarketresearch.com +91 9169164321

By Types

•Solid Lipid Nanoparticles (SLN)

•Nanostructured Lipid Carriers (NLC)

•Liposomes

•Lipid–Polymer Hybrid Nanoparticles

•Others

Cosmetics and Dermatology

Key Players :

Merck KGaA (Germany)

Precision NanoSystems (Canada)

Evonik Industries (Germany)

Genevant Sciences (U.S.)

Exelead (U.S.)

Avanti Polar Lipids (U.S.)

Nippon Fine Chemical (Japan)

Email:  help@intelmarketresearch.com +91 9169164321